With the FDA reviewing psychedelic treatments, approval of such drugs would lead to DEA reclassification and open a world of new mental health care. A polarized light micrograph of serotonin—a ...
New studies show that psychedelics could unlock safer treatments for chronic pain, mood disorders, and even neuroprotection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback